TY - JOUR
T1 - Recessive TTN truncating mutations define novel forms of core myopathy with heart disease
AU - Chauveau, Claire
AU - Bonnemann, Carsten G.
AU - Julien, Cedric
AU - Kho, Ay Lin
AU - Marks, Harold
AU - Talim, Beril
AU - Maury, Philippe
AU - Arne-Bes, Marie Christine
AU - Uro-Coste, Emmanuelle
AU - Alexandrovich, Alexander
AU - Vihola, Anna
AU - Schafer, Sebastian
AU - Kaufmann, Beth
AU - Medne, Livija
AU - Huebner, Norbert
AU - Foley, A. Reghan
AU - Santi, Mariarita
AU - Udd, Bjarne
AU - Topaloglu, Haluk
AU - Moore, Steven A.
AU - Gotthardt, Michael
AU - Samuels, Mark E.
AU - Gautel, Mathias
AU - Ferreiro, Ana
PY - 2014/2/15
Y1 - 2014/2/15
N2 - Core myopathies (CM), the main non-dystrophic myopathies in childhood, remain genetically unexplained in many cases. Heart disease is not considered part of the typical CM spectrum. No congenital heart defect has been reported, and childhood-onset cardiomyopathy has been documented in only two CM families with homozygous mutations of the TTN gene. TTN encodes titin, a giant protein of striated muscles. Recently, heterozygous TTN truncating mutations have also been reported as a major cause of dominant dilated cardiomyopathy. However, relatively few TTN mutations and phenotypes are known, and titin pathophysiological role in cardiac and skeletal muscle conditions is incompletely understood. We analyzed a series of 23 families with congenital CM and primary heart disease using TTN M-line-targeted sequencing followed in selected patients by whole-exome sequencing and functional studies. We identified seven novel homozygous or compound heterozygous TTN mutations (five in the M-line, five truncating) in 17 patients. Heterozygous parents were healthy. Phenotype analysis identified four novel titinopathies, including cardiac septal defects, left ventricular non-compaction, EmeryDreifuss muscular dystrophy or arthrogryposis. Additionally, in vitro studies documented the first-reported absence of a functional titin kinase domain in humans, leading to a severe antenatal phenotype. We establish that CM are associated with a large range of heart conditions of which TTN mutations are a major cause, thereby expanding the TTN mutational and phenotypic spectrum. Additionally, our results suggest titin kinase implication in cardiac morphogenesis and demonstrate that heterozygous TTN truncating mutations may not manifest unless associated with a second mutation, reassessing the paradigm of their dominant expression.
AB - Core myopathies (CM), the main non-dystrophic myopathies in childhood, remain genetically unexplained in many cases. Heart disease is not considered part of the typical CM spectrum. No congenital heart defect has been reported, and childhood-onset cardiomyopathy has been documented in only two CM families with homozygous mutations of the TTN gene. TTN encodes titin, a giant protein of striated muscles. Recently, heterozygous TTN truncating mutations have also been reported as a major cause of dominant dilated cardiomyopathy. However, relatively few TTN mutations and phenotypes are known, and titin pathophysiological role in cardiac and skeletal muscle conditions is incompletely understood. We analyzed a series of 23 families with congenital CM and primary heart disease using TTN M-line-targeted sequencing followed in selected patients by whole-exome sequencing and functional studies. We identified seven novel homozygous or compound heterozygous TTN mutations (five in the M-line, five truncating) in 17 patients. Heterozygous parents were healthy. Phenotype analysis identified four novel titinopathies, including cardiac septal defects, left ventricular non-compaction, EmeryDreifuss muscular dystrophy or arthrogryposis. Additionally, in vitro studies documented the first-reported absence of a functional titin kinase domain in humans, leading to a severe antenatal phenotype. We establish that CM are associated with a large range of heart conditions of which TTN mutations are a major cause, thereby expanding the TTN mutational and phenotypic spectrum. Additionally, our results suggest titin kinase implication in cardiac morphogenesis and demonstrate that heterozygous TTN truncating mutations may not manifest unless associated with a second mutation, reassessing the paradigm of their dominant expression.
KW - TIBIAL MUSCULAR-DYSTROPHY
KW - EARLY RESPIRATORY-FAILURE
KW - MULTI-MINICORE DISEASE
KW - C-TERMINAL TITIN
KW - DILATED CARDIOMYOPATHY
KW - HYPERTROPHIC CARDIOMYOPATHY
KW - CONGENITAL MYOPATHY
KW - HEREDITARY MYOPATHY
KW - IMMUNOELECTRON MICROSCOPY
KW - CARDIAC INVOLVEMENT
U2 - 10.1093/hmg/ddt494
DO - 10.1093/hmg/ddt494
M3 - Article
SN - 0964-6906
VL - 23
SP - 980
EP - 991
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 4
ER -